Cardinal Health agrees to extend CVS deal: Cardinal Health stock gains 1.33 percent

Published on 10/02/2026 at 15:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health reaffirmed 13 to 15 percent growth guidance. Cardinal Health stock costs EUR 206.35 on October 2, 2026, plus 1.33 percent versus EUR 203.65.

Belebtes NYSE-Handelsparkett mit Healthcare-Sektor-Anzeigetafeln und Tradern — NYSE-Börsenparkett mit Healthcare-Charts zeigt Cardinal Health Inc. Aktienhandel live – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health (ISIN US14149Y1082) was trading at EUR 206.35 at Lang & Schwarz on October 2, 2026, at 3:06 p.m. CEST, plus 1.33 percent versus the prior close of EUR 203.65. The company entered a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, as Cardinal Health reported on October 1, 2026.

CVS agreement secures long-term volume

The agreement keeps the existing scope of distribution services in place through June 30, 2032. In the same release, Cardinal Health reaffirmed fiscal year 2027 non-GAAP earnings per share growth guidance of 13.00 percent to 15.00 percent, equivalent to USD 12.40 to USD 12.60.

The timing gives the distribution business a visible contract horizon while management enters the next reporting cycle. Cardinal Health said further updates may come with its first-quarter fiscal year 2027 earnings call on November 5, 2026, according to Cardinal Health.

Fiscal 2026 set a higher base

For fiscal year 2026, revenue increased 14.00 percent to USD 254.2 billion from USD 222.6 billion in fiscal year 2025. GAAP diluted earnings per share rose 12.00 percent to USD 7.23 from USD 6.45, while operating cash flow reached USD 5.2 billion.

The latest results also show why the guidance range matters. Fiscal year 2026 non-GAAP diluted earnings per share increased 37.00 percent to USD 11.26, and the company expects fiscal year 2027 growth of 13.00 percent to 15.00 percent on that adjusted base, according to Yahoo Finance.

Stock rises above its prior close

Cardinal Health had a market capitalization of USD 53.9 billion as of October 1, 2026. Its primary exchange is the NYSE, where the stock's 52-week range was USD 150.78 to USD 258.30 on October 1, 2026, placing the Lang & Schwarz euro quote below the high in a separate currency view.

At Lang & Schwarz, the stock was trading at EUR 206.35 on October 2, 2026, at 3:06 p.m. CEST, plus 1.33 percent versus the EUR 203.65 prior close. The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.